“duchenne-muscular-dystrophy” Archives

in
Entry Author Date Location
Busy FDA Week Ends With Two Drug Approvals: Another Might Be on Way 05/27/16 Boston
Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More 05/27/16 National
Sarepta Saga Drags On as FDA Delays Decision on Duchenne Drug 05/25/16 Boston
Biogen Turns To UPenn Gene Therapy Pioneers in Wide-Ranging Alliance 05/16/16 Boston
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More 04/28/16 Boston
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
BioMarin Heads to FDA With Mixed Data For Rare Disease Drug 03/21/16 San Francisco
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More 03/10/16 Boston
West Coast Bio Roundup: UCLA Cashes In, BioMarin Tries Again & More 03/04/16 San Francisco
East Coast Biotech Roundup: Ribon, Syndax, Aldeyra & More 03/03/16 Boston
Spurned in Duchenne, BioMarin Will Seek Approval For Batten Drug 03/03/16 San Francisco
Déjà Vu for PTC as FDA Declines to Consider Duchenne Drug App 02/23/16 New York
East Coast Biotech Roundup: Scangos, CRISPR, Yumanity, Synlogic & More 02/11/16 New York
Gene Editing Execs Talk Scientific, Regulatory Hurdles At BIO Panel 02/10/16 Boston
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Safety Issues Spur Foundation-Backed Akashi to Suspend Duchenne Trial 01/26/16 Boston
East Coast Biotech Roundup: Alkermes, Zafgen, Snowmaggedon & More 01/22/16 Boston
FDA Rejects BioMarin’s Duchenne Drug, Sarepta Up Next 01/14/16 San Francisco
Warp Drive, Surface, Bamboo Cut Deals on Eve of J.P. Morgan 01/11/16 Boston
East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More 01/08/16 Boston
Scholar Rock Rolls Up $36M To Move Muscle Drug To Clinical Trials 01/04/16 Boston
West Coast Bio Roundup: Gene Edit Talk, Not Poor ORIC, BioMarin Sags 12/04/15 San Francisco
At Duchenne Panel, Parents Plead With Experts, FDA Decision Looms 11/24/15 San Francisco
East Coast Biotech Roundup: Pfizergan, Zafgen, Codiak, Boston Pharma 11/23/15 Boston
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Biogen Helps Put $42.5M Into a Father’s Duchenne Gene Therapy Quest 11/05/15 Boston
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
PTC Unveils Mixed Duchenne Results, But Plots an FDA Filing 10/15/15 New York
Page 1 of 4 next page »